Vyne Therapeutics Inc (VYNE) — Cash Flow Quality Index

Latest as of March 2022: -1.94x

Vyne Therapeutics Inc (VYNE) has a Cash Flow Quality Index of -1.94x as of March 2022. Operating cash flow of $-9.04 Million is below net income of $4.67 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Vyne Therapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-1.94x
Operating CF / Net Income

Operating Cash Flow

$-9.04 Million
USD

Net Income

$4.67 Million
USD

Data as of

Mar 2022
Most recent filing

Annual Cash Flow Quality Index for Vyne Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Vyne Therapeutics Inc. For live market cap and the full company financial profile, see VYNE market cap overview.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.